This project was funded under grant number U18 HS15830 from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services. The opinions expressed in this document are those of the authors and do not reflect the official position of AHRQ or the U.S. Department of Health and Human Services.

Coumadin is a registered trademark of Bristol-Myers Squibb Company. Innovin is a registered trademark of Dade Behring, Inc. PowerPoint is a registered trademark of Microsoft Corporation. All other trademarks are property of their respective owners.

Privacy Policy

Terms of Use